Search Results - Hui-Chuan Sun

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Adjuvant therapies after curative treatments for hepatocellular carcinoma: Current status and prospects by Xiao-Dong Zhu, Kang-Shuai Li, Hui-Chuan Sun

    Published in Genes and Diseases (2020-09-01)
    Get full text
    Article


  2. 2

    Targeting angiogenesis for liver cancer: Past, present, and future by Xiao-Dong Zhu, Zhao-You Tang, Hui-Chuan Sun

    Published in Genes and Diseases (2020-09-01)
    Get full text
    Article


  3. 3

    PCSK9 promotes tumor growth by inhibiting tumor cell apoptosis in hepatocellular carcinoma by Shi-Zhe Zhang, Xiao-Dong Zhu, Long-Hai Feng, Xiao-Long Li, Xue-Feng Liu, Hui-Chuan Sun, Zhao-You Tang

    Published in Experimental Hematology & Oncology (2021-03-01)
    Get full text
    Article


  4. 4

    The development and prospects of liver surgery by Hui-Chuan Sun, Ying-Hao Shen, Cheng Huang, Xiao-Dong Zhu, Chang-Jun Tan, Zhao-You Tang, Jia Fan, Jian Zhou

    Published in Clinical Surgical Oncology (2023-03-01)
    Get full text
    Article


  5. 5

    Depth of radiographic response as an independent prognostic factor for patients with initially unresectable hepatocellular carcinoma receiving hepatectomy following targeted therap... by Bin Xu, Lu-Na Wang, Zi-Yi Wang, Tian He, Xiao-Dong Zhu, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang

    Published in Liver Cancer (2024-09-01)
    Get full text
    Article


  6. 6

    Criteria for identifying potentially resectable patients with initially oncologically unresectable hepatocellular carcinoma before treatment with lenvatinib plus an anti–PD–1 antib... by Bin Xu, Xiao-Dong Zhu, Ying-Hao Shen, Jin-Jin Zhu, Jie Liu, Mei-Ling Li, Pei-Wen Tang, Jian Zhou, Jia Fan, Hui-Chuan Sun, Cheng Huang

    Published in Frontiers in Immunology (2022-11-01)
    Get full text
    Article


  7. 7

    FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma by Hui Li, Wenxin Xu, Qinghai Ye, Qiang Yu, Jialei Weng, Shaoqing Liu, Minghao Xu, Yinghao Shen, Hui-Chuan Sun, Yufei Zhao, Peiyi Xie, Mincheng Yu, Bugang Liang, Junbo Chen

    Published in Journal for ImmunoTherapy of Cancer (2025-05-01)
    Get full text
    Article


  8. 8

    Sintilimab plus bevacizumab followed by resection in intermediate-stage hepatocellular carcinoma: a phase Ib clinical trial with biomarker analysis by Jia Fan, Shuang-Jian Qiu, Xiao-Ying Wang, Qiang Gao, Ying-Hong Shi, Yuan Ji, Cheng Huang, Hui-Chuan Sun, Xiao-Dong Zhu, Zi-Yi Wang, Ying-Hao Shen

    Published in BMJ Oncology (2024-12-01)
    Get full text
    Article


  9. 9

    The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma. by Ling-Qun Kong, Xiao-Dong Zhu, Hua-Xiang Xu, Ju-Bo Zhang, Lu Lu, Wen-Quan Wang, Qiang-Bo Zhang, Wei-Zhong Wu, Lu Wang, Jia Fan, Zhao-You Tang, Hui-Chuan Sun

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  10. 10

    The Safety Profile of Hepatectomy Following Preoperative Systemic Therapy with Lenvatinib Plus Anti-PD-1 Antibodies Versus Hepatectomy Alone in Patients With Hepatocellular Carcino... by Ying-Hao Shen, MD, Cheng Huang, MD, Xiao-Dong Zhu, MD, Ming-Hao Xu, BS, Zhao-Shuo Chen, MS, Chang-Jun Tan, MD, Jian Zhou, MD, Jia Fan, MD, Hui-Chuan Sun, MD

    Published in Annals of Surgery Open (2022-06-01)
    Get full text
    Article


  11. 11

    The prognostic value of systemic immune-inflammation index in patients with unresectable hepatocellular carcinoma treated with immune-based therapy by Tian He, Bin Xu, Lu-Na Wang, Zi-Yi Wang, Huan-Chen Shi, Cheng-Jie Zhong, Xiao-Dong Zhu, Ying-Hao Shen, Jian Zhou, Jia Fan, Hui-Chuan Sun, Bo Hu, Cheng Huang

    Published in Biomarker Research (2025-01-01)
    Get full text
    Article


  12. 12

    Suppression of natural killer cells by sorafenib contributes to prometastatic effects in hepatocellular carcinoma. by Qiang-Bo Zhang, Hui-Chuan Sun, Ke-Zhi Zhang, Qing-An Jia, Yang Bu, Miao Wang, Zong-Tao Chai, Quan-Bao Zhang, Wen-Quan Wang, Ling-Qun Kong, Xiao-dong Zhu, Lu Lu, Wei-Zhong Wu, Lu Wang, Zhao-You Tang

    Published in PLoS ONE (2013-01-01)
    Get full text
    Article


  13. 13

    Efficacy and safety of combined targeted therapy and immunotherapy versus targeted monotherapy in older patients with uHCC by Yu Li, Jian-Hong Zhong, Xiao-Dong Zhu, Chuang-Ye Han, Jia-Bei Wang, Hong-Zhi Liu, Kuan Hu, Yang-Xun Pan, Hui-Chuan Sun, Tao Peng, Lian-Xin Liu, Yong-Yi Zeng, Le-Du Zhou, Li Xu, Nan-Ya Wang

    Published in Frontiers in Oncology (2025-04-01)
    Get full text
    Article


  14. 14

    CXCL6 Reshapes Lipid Metabolism and Induces Neutrophil Extracellular Trap Formation in Cholangiocarcinoma Progression and Immunotherapy Resistance by Tian He, Zi‐Yi Wang, Bin Xu, Cheng‐Jie Zhong, Lu‐Na Wang, Huan‐Chen Shi, Zi‐Yue Yang, Shi‐Qi Zhou, Hui Li, Bo Hu, Xiao‐Dong Zhu, Ying‐Hao Shen, Jian Zhou, Jia Fan, Hui‐Chuan Sun, Cheng Huang

    Published in Advanced Science (2025-07-01)
    Get full text
    Article


  15. 15

    The pattern of tumor progression on first-line immune checkpoint inhibitor-based systemic therapy for Chinese advanced hepatocellular carcinoma –CLEAP 004 study by Chao-Xu Yang, Yang-Xun Pan, Feng Ye, Xiao-Dong Zhu, Jun Xue, Xi Li, Zhen-Gang Yuan, Lan Zhang, Li Xu, Yong-Jun Chen, Nan-Ya Wang, Hui-Chuan Sun, Xiu-Feng Liu, China Liver Cancer Study Group Young Investigators (CLEAP)

    Published in Frontiers in Immunology (2024-04-01)
    Get full text
    Article


  16. 16

    Proteomic and metabolomic features in patients with HCC responding to lenvatinib and anti-PD1 therapy by Zhong-Chen Li, Jie Wang, He-Bin Liu, Yi-Min Zheng, Jian-Hang Huang, Jia-Bin Cai, Lei Zhang, Xin Liu, Ling Du, Xue-Ting Yang, Xiao-Qiang Chai, Ying-Hua Jiang, Zheng-Gang Ren, Jian Zhou, Jia Fan, De-Cai Yu, Hui-Chuan Sun, Cheng Huang, Feng Liu

    Published in Cell Reports (2024-03-01)
    Get full text
    Article


  17. 17

    Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 stu... by Guo-Ming Shi, Xiao-Yong Huang, Dong Wu, Hui-Chuan Sun, Fei Liang, Yuan Ji, Yi Chen, Guo-Huan Yang, Jia-Cheng Lu, Xian-Long Meng, Xin-Ying Wang, Lei Sun, Ning-Ling Ge, Xiao-Wu Huang, Shuang-Jian Qiu, Xin-Rong Yang, Qiang Gao, Yi-Feng He, Yang Xu, Jian Sun, Zheng-Gang Ren, Jia Fan, Jian Zhou

    Published in Signal Transduction and Targeted Therapy (2023-03-01)
    Get full text
    Article


  18. 18

    Radiographic and α-fetoprotein response predict pathologic complete response to immunotherapy plus a TKI in hepatocellular carcinoma: a multicenter study by Cheng Huang, Xiao-Dong Zhu, Ying-Hao Shen, Bin Xu, Dong Wu, Yuan Ji, Ling-Li Chen, Tian-Qiang Song, Wei Zhang, Zhi-Ming Zeng, Hua-Sheng Huang, Kui Wang, Lan-Qing Huang, Yong-Jun Chen, Yu-Chen Yang, Le-Du Zhou, Guo Long, Hai-Tao Zhao, Yun-Chao Wang, Ning-Ling Ge, Yi Chen, Chang-Jun Tan, Jian Zhou, Jia Fan, Hui-Chuan Sun

    Published in BMC Cancer (2023-05-01)
    Get full text
    Article


  19. 19

    GUIDE: a prospective cohort study for blood-based early detection of gastrointestinal cancers using targeted DNA methylation and fragmentomics sequencing by Ao Huang, De-Zhen Guo, Zhi-Xi Su, Yun-Shi Zhong, Liang Liu, Zhi-Guo Xiong, Dong-Li He, Bin Yan, Quan-Lin Li, Zhen Feng, Wen-Quan Wang, Pin-Xiang Lu, Meng-Jiang He, Zhi-Peng Qi, Qi Guo, Jian-Wen Cheng, Shi-Yu Zhang, Wei Guo, Qing Li, Guo-Yong Lin, Hui-Chuan Sun, Shuang-Jian Qiu, Qi-Ye He, Jia Fan, Ajay Goel, Rui Liu, Gang Jin, Xin-Rong Yang, Jian Zhou

    Published in Molecular Cancer (2025-06-01)
    Get full text
    Article


Search Tools: